BioSpace News Archive

The World Health Organization commemorates World Tuberculosis Day to raise awareness about the health, social and economic consequences of this disease and to acknowledge the broader impact of COVID-19 for people with TB, including disruptions to essential TB services.

NeuroTrauma Sciences, LLC (NTS), a private biopharmaceutical company developing a portfolio of disease-modifying therapeutic candidates to treat the devastating effects of acquired brain injury, today announced the expansion of its executive management team with several key appointments:

Waters Bills Would Eliminate Cost-Sharing for Insulin-Dependent Seniors and Provide Needed Grants for Diabetes Prevention, Care and Treatment

Based on the model established at Blumberg Institute’s highly successful Pennsylvania Biotechnology Center (PABC), B.Labs will further accelerate scientific development in the booming University City, Philadelphia’s Life Science ecosystem

TELA Bio, Inc. (“TELA”), a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction, today reported financial results for the fourth quarter and full year ended December 31, 2020. Recent Highlights

NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company, today announced that it has received approval of an amendment to its Contingent Value Rights (CVR) agreement from a majority of the holders of a majority of the outstanding CVRs, incentivizing the evaluation of Gemcabene as a treatment for COVID-19.

Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company announces fourth quarter and full year 2020 results and provides a general business update on March 24, 2021.

Tempus, a leader in artificial intelligence and precision medicine, today announced that the U.S. Food & Drug Administration (FDA) has granted the company Breakthrough Device Designation for its ECG Analysis Platform.

Aspen Surgical Products, Inc., a leader in surgical disposable products, announced the acquisition of BlueMed Medical Supplies, Inc..

Biocom California and the California Life Sciences Association (CLSA) today released data analyzing the potential impact of international reference pricing (foreign price controls) on California’s biopharmaceutical innovation ecosystem, including investment into small company capital formation and the new drug development pipeline.